Pneumocystis Pneumonia News and Research

RSS
Initially described as “plasma cell pneumonia”, pulmonary infection with the microorganism Pneumocystis jiroveci (formerly known as Pnemocystis carinii) was first identified in malnourished infants, especially those in orphanages, at the conclusion of the Second World War. Today this disease, manifesting as a severe and often fatal pneumonia in immunocompromised patients, is of increasing importance to pediatricians and other specialists around the world.
New category of immunotherapy appears safe to use in patients with both cancer and HIV

New category of immunotherapy appears safe to use in patients with both cancer and HIV

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Despite availability of life-saving medicaiton, annual deaths due to fungal meningitis are still over 180,000

Improving fungal disease diagnostics could help battle against antimicrobial resistance

Improving fungal disease diagnostics could help battle against antimicrobial resistance

Better fungal disease diagnostics could be critical to fight against antimicrobial resistance

Better fungal disease diagnostics could be critical to fight against antimicrobial resistance

Study: Fungal asthma in UK greatly exceeds prior estimates

Study: Fungal asthma in UK greatly exceeds prior estimates

Rising shortages of key antibiotics raise serious concerns about effects on patient care

Rising shortages of key antibiotics raise serious concerns about effects on patient care

New model for HIV-1 infection offers promising option for clinical research

New model for HIV-1 infection offers promising option for clinical research

Genome sequencing may help identify new targets to treat Pneumocystis pneumonia

Genome sequencing may help identify new targets to treat Pneumocystis pneumonia

Environmental factors affect pneumonia hospitalization in HIV

Environmental factors affect pneumonia hospitalization in HIV

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

Nostrum, VCU sign license agreement to develop inhaled dapsone for respiratory diseases

NIH awards LSUHSC $9 million grant to develop pneumonia vaccine

NIH awards LSUHSC $9 million grant to develop pneumonia vaccine

Lab21 acquires molecular diagnostics company Myconostica Ltd

Lab21 acquires molecular diagnostics company Myconostica Ltd

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

Myconostica presents data of MycAssay for Pneumocystis detection

Myconostica presents data of MycAssay for Pneumocystis detection

LSUHSC Professor awarded $2.1M grant to determine role of PCP

LSUHSC Professor awarded $2.1M grant to determine role of PCP

Immtech and BioAlliance sign agreement on Pafuramidine for African sleeping sickness

Immtech and BioAlliance sign agreement on Pafuramidine for African sleeping sickness

Immtech receives $5.1 million to tackle trypanosomiasis and leishmania

Immtech receives $5.1 million to tackle trypanosomiasis and leishmania